GM

Gabriel Marie Nicolas Aleth Pascal Du Pont De Romemont

Director Director DIN 07488216
DIN 07488216 First appointment Apr 2016 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Apr 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Gabriel Marie Nicolas Aleth Pascal Du Pont De Romemont

Data last updated:

Gabriel Marie Nicolas Aleth Pascal Du Pont De Romemont was a Director at Curium Pharma (India) Private Limited (2016–2018). The company operates in Pharma.

DIN 07488216
Primary Designation Director
Industry Pharma
First Appointment 18 Apr 2016

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Apr 20162004₹41.38 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Curium Pharma (India) Private Limited
Premium access

Shareholding and investment profile for Gabriel Marie Nicolas Aleth Pascal Du Pont De Romemont

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gabriel Marie Nicolas Aleth Pascal Du Pont De Romemont

Gabriel Marie Nicolas Aleth Pascal Du Pont De Romemont was first appointed on 18 Apr 2016 as Director at Curium Pharma (India) Private Limited.

Gabriel Marie Nicolas Aleth Pascal Du Pont De Romemont held 1 earlier board appointment: Curium Pharma (India) Private Limited (Director, 18 Apr 2016 to 01 Mar 2018).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available